Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

P Hurst

Showing results (211-220 of 276) with videos related to

Pageof 28
Sort By:
Journal of Pharmaceutical and Biomedical Analysis|May 4, 2023
Noncompetitive immunoassay optimized for pharmacokinetic assessments of biologically active efruxiferminAdam S Kinne, Erik J Tillman, Sanofar J Abdeen, et al.
Transplantation|November 27, 2008
Progressive multifocal leukoencephalopathy and use of mycophenolate mofetil after kidney transplantationRobert T Neff, Frank P Hurst, Edward M Falta, et al.
Journal of Medicinal Chemistry|July 17, 2013
The importance of hydrogen bonding and aromatic stacking to the affinity and efficacy of cannabinoid receptor CB2 antagonist, 5-(4-chloro-3-methylphenyl)-1-[(4-methylphenyl)methyl]-N-[(1S,2S,4R)-1,3,3-trimethylbicyclo[2.2.1]hept-2-yl]-1H-pyrazole-3-carboxamide (SR144528)Evangelia Kotsikorou, Frank Navas, Michael J Roche, et al.
Transplantation|January 21, 2011
Incidence, predictors, costs, and outcome of renal cell carcinoma after kidney transplantation: USRDS experienceFrank P Hurst, Rahul M Jindal, Lindsey J Graham, et al.
The Journal of Biological Chemistry|June 28, 2007
Helix 8 Leu in the CB1 cannabinoid receptor contributes to selective signal transduction mechanismsSharon Anavi-Goffer, Daniel Fleischer, Dow P Hurst, et al.
European Journal of Medicinal Chemistry|July 26, 2015
Synthesis, pharmacological evaluation and docking studies of pyrrole structure-based CB2 receptor antagonistsGiulio Ragusa, María Gómez-Cañas, Paula Morales, et al.
Journal of Medicinal Chemistry|June 17, 2016
Chromenopyrazole, a Versatile Cannabinoid Scaffold with in Vivo Activity in a Model of Multiple SclerosisPaula Morales, María Gómez-Cañas, Gemma Navarro, et al.
American Journal of Nephrology|January 14, 2010
New-onset diabetes after hemodialysis initiation: impact on survivalMoro O Salifu, Kevin C Abbott, Serhat Aytug, et al.
ACS Medicinal Chemistry Letters|January 19, 2023
Thienopyrimidine Derivatives as GPR55 Receptor Antagonists: Insight into Structure-Activity RelationshipLaura Figuerola-Asencio, Paula Morales, Pingwei Zhao, et al.
European Journal of Medicinal Chemistry|January 28, 2023
Design, synthesis, and evaluation of substituted alkylindoles that activate G protein-coupled receptors distinct from the cannabinoid CB<sub>1</sub> and CB<sub>2</sub> receptorsToni Kline, Cong Xu, Faith R Kreitzer, et al.
Pageof 28

Showing results (211-220 of 276) with videos related to

Sort By:
Pageof 28
Journal of Pharmaceutical and Biomedical Analysis|May 4, 2023
Noncompetitive immunoassay optimized for pharmacokinetic assessments of biologically active efruxiferminAdam S Kinne, Erik J Tillman, Sanofar J Abdeen, et al.
Transplantation|November 27, 2008
Progressive multifocal leukoencephalopathy and use of mycophenolate mofetil after kidney transplantationRobert T Neff, Frank P Hurst, Edward M Falta, et al.
Journal of Medicinal Chemistry|July 17, 2013
The importance of hydrogen bonding and aromatic stacking to the affinity and efficacy of cannabinoid receptor CB2 antagonist, 5-(4-chloro-3-methylphenyl)-1-[(4-methylphenyl)methyl]-N-[(1S,2S,4R)-1,3,3-trimethylbicyclo[2.2.1]hept-2-yl]-1H-pyrazole-3-carboxamide (SR144528)Evangelia Kotsikorou, Frank Navas, Michael J Roche, et al.
Transplantation|January 21, 2011
Incidence, predictors, costs, and outcome of renal cell carcinoma after kidney transplantation: USRDS experienceFrank P Hurst, Rahul M Jindal, Lindsey J Graham, et al.
The Journal of Biological Chemistry|June 28, 2007
Helix 8 Leu in the CB1 cannabinoid receptor contributes to selective signal transduction mechanismsSharon Anavi-Goffer, Daniel Fleischer, Dow P Hurst, et al.
European Journal of Medicinal Chemistry|July 26, 2015
Synthesis, pharmacological evaluation and docking studies of pyrrole structure-based CB2 receptor antagonistsGiulio Ragusa, María Gómez-Cañas, Paula Morales, et al.
Journal of Medicinal Chemistry|June 17, 2016
Chromenopyrazole, a Versatile Cannabinoid Scaffold with in Vivo Activity in a Model of Multiple SclerosisPaula Morales, María Gómez-Cañas, Gemma Navarro, et al.
American Journal of Nephrology|January 14, 2010
New-onset diabetes after hemodialysis initiation: impact on survivalMoro O Salifu, Kevin C Abbott, Serhat Aytug, et al.
ACS Medicinal Chemistry Letters|January 19, 2023
Thienopyrimidine Derivatives as GPR55 Receptor Antagonists: Insight into Structure-Activity RelationshipLaura Figuerola-Asencio, Paula Morales, Pingwei Zhao, et al.
European Journal of Medicinal Chemistry|January 28, 2023
Design, synthesis, and evaluation of substituted alkylindoles that activate G protein-coupled receptors distinct from the cannabinoid CB<sub>1</sub> and CB<sub>2</sub> receptorsToni Kline, Cong Xu, Faith R Kreitzer, et al.
Pageof 28